700,000 Shares in Oscar Health, Inc. (NYSE:OSCR) Bought by Integral Health Asset Management LLC

Integral Health Asset Management LLC purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 700,000 shares of the company's stock, valued at approximately $9,408,000. Integral Health Asset Management LLC owned about 0.28% of Oscar Health as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of OSCR. Tower Research Capital LLC TRC grew its stake in shares of Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock valued at $89,000 after buying an additional 4,185 shares in the last quarter. KBC Group NV raised its stake in shares of Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after purchasing an additional 2,555 shares during the period. Alberta Investment Management Corp acquired a new position in shares of Oscar Health during the fourth quarter worth $138,000. Virtu Financial LLC purchased a new position in shares of Oscar Health in the fourth quarter valued at $140,000. Finally, Potentia Wealth acquired a new stake in Oscar Health during the 4th quarter valued at $141,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Oscar Health presently has an average rating of "Hold" and a consensus price target of $20.08.

Insiders Place Their Bets

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now owns 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 24.39% of the stock is currently owned by company insiders.

Oscar Health Stock Up 0.1%

NYSE OSCR traded up $0.02 during trading hours on Thursday, reaching $16.56. 5,929,517 shares of the company traded hands, compared to its average volume of 4,148,641. The stock has a market capitalization of $4.15 billion, a PE ratio of -827.59 and a beta of 1.75. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79. The company has a 50 day moving average of $13.38 and a two-hundred day moving average of $14.64.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. During the same quarter last year, the company posted $0.62 earnings per share. The company's quarterly revenue was up 42.2% compared to the same quarter last year. As a group, equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.